STI-AMR kits: now available for commercialization

NYtor STI-AMR kits:

These RUO kits have already found successful application in several clinical studies.
Literature references and links to the PDF are:

• Nijhuis, EJCMID (2020)
  Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis including relevant resistance-associated mutations in a single center in the Netherlands.
• de Korne-Elenbaas, STD (2020)
  Simultaneous detection of Neisseria gonorrhoeae and fluoroquinolone resistance mutations to enable rapid prescription of oral antibiotics.